Biodel Inc (NASDAQ:BIOD)

1.14
Delayed Data
As of Apr 24
 -0.13 / -10.24%
Today’s Change
0.99
Today|||52-Week Range
2.51
-14.29%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$72.7M

Company Description

Biodel, Inc. is a specialty pharmaceutical company that develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. It is developing novel forms of insulin and other peptide hormones for use in treating diabetes and its complications, including hyperglycemia, hypoglycemia, cardiovascular complications and weight control. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT.

Contact Information

Biodel, Inc.
100 Saw Mill Road
Danbury Connecticut 06810
P:(203) 796-5000
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Errol B. De SouzaPresident, Chief Executive Officer & Director
Erik SteinerVice President-Operations
Gary G. GemignaniChief Financial Officer
Alan Seth KrasnerChief Medical Officer
Paul S. BavierSecretary & Chief Compliance Officer

To view my watchlist

Not a member yet?

Sign up now for a free account